v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from (used in) operating activities [abstract]      
Loss for the year $ (52,159,120) $ (46,408,453) $ (13,207,200)
Adjustments to reconcile profit (loss) [abstract]      
Finance costs 375,000 0 0
Finance income (570,446) (17,808) (302,720)
Share-based compensation 42,228,494 35,734,452 4,703,254
Change in fair value of warrant liability (3,490,900) (386,900) 0
Gain on sale of fixed assets (6,078) 0 0
Deferred income tax provision 351,451 187,742 160,838
Cash flows from (used in) operations before changes in working capital (13,271,599) (10,890,967) (8,645,828)
Change in amounts receivable 346,370 (449,674) 19,562
Change in prepaid expenses 161,901 (1,262,023) (135,897)
Change in trade payables and accrued liabilities (415,814) 1,326,764 565,410
Net cash used in operating activities (13,179,142) (11,275,900) (8,196,753)
Cash flows from (used in) financing activities [abstract]      
Proceeds of private placement, net of issuance costs 26,642,090 0 0
Initial Public Offering, net of issue costs 0 27,979,905 0
Purchase of shares under ELOC, net of issuance costs 5,999,500 0 0
Option exercise 40,000 2,057,500 2,497,500
Warrant exercise 0 1,614,750 0
Principal reduction in lease liability (229,906) (42,289) 0
Net cash from financing activities 32,451,684 31,609,866 2,497,500
Cash flows from (used in) investing activities [abstract]      
Acquisition of property and equipment (22,532) (5,245) (6,938)
Exploration and evaluation assets (10,844,549) (3,779,367) (3,930,790)
Finance income 570,446 17,808 302,720
Proceeds from disposition of fixed assets 6,078 0 0
Net cash used in investing activities (10,290,557) (3,766,804) (3,635,008)
Effect of exchange rate changes on cash and cash equivalents (63,348) (156,372) (20,407)
NET DECREASE IN CASH AND CASH EQUIVALENTS 8,918,637 16,410,790 (9,354,668)
CASH AND CASH EQUIVALENTS, beginning of year 18,861,029 2,450,239 11,804,907
CASH AND CASH EQUIVALENTS, end of year 27,779,666 18,861,029 2,450,239
SUPPLEMENTAL INFORMATION:      
Depreciation of assets capitalized to exploration and evaluation assets 124,387 80,580 4,526
Share-based compensation included in exploration and evaluation assets 840,620 1,682,382 127,670
Value of broker warrants issued 0 519,100 0
Right of use asset and lease liability at inception 0 737,506 0
Amendment to right of use asset and lease liability 40,973 0 0
Lease finance interest capitalized to exploration and evaluation assets 83,862 55,795 0
Gain on lease amendment credited to exploration and evaluation assets $ (2,317) $ 0 $ 0